Novo Nordisk As Stock Alpha and Beta Analysis
| NONOF Stock | USD 109.00 0.70 0.64% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Novo Nordisk AS. It also helps investors analyze the systematic and unsystematic risks associated with investing in Novo Nordisk over a specified time horizon. Remember, high Novo Nordisk's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Novo Nordisk's market risk premium analysis include:
Beta 0.57 | Alpha (0.31) | Risk 2.48 | Sharpe Ratio (0.14) | Expected Return (0.35) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Novo |
Novo Nordisk Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Novo Nordisk market risk premium is the additional return an investor will receive from holding Novo Nordisk long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Novo Nordisk. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Novo Nordisk's performance over market.| α | -0.31 | β | 0.57 |
Novo Nordisk expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Novo Nordisk's Buy-and-hold return. Our buy-and-hold chart shows how Novo Nordisk performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Novo Nordisk Market Price Analysis
Market price analysis indicators help investors to evaluate how Novo Nordisk pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By understating and applying Novo Nordisk pink sheet market price indicators, traders can identify Novo Nordisk position entry and exit signals to maximize returns.
Novo Nordisk Return and Market Media
The median price of Novo Nordisk for the period between Thu, Sep 12, 2024 and Wed, Dec 11, 2024 is 114.22 with a coefficient of variation of 8.38. The daily time series for the period is distributed with a sample standard deviation of 9.67, arithmetic mean of 115.5, and mean deviation of 7.73. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Novo Nordisk Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Novo or other pink sheets. Alpha measures the amount that position in Novo Nordisk AS has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novo Nordisk in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novo Nordisk's short interest history, or implied volatility extrapolated from Novo Nordisk options trading.
Build Portfolio with Novo Nordisk
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Novo Pink Sheet
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:Check out Novo Nordisk Backtesting, Novo Nordisk Valuation, Novo Nordisk Correlation, Novo Nordisk Hype Analysis, Novo Nordisk Volatility, Novo Nordisk History and analyze Novo Nordisk Performance. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Novo Nordisk technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.